Malvern, Pennsylvania
United States
85
2026-03-19
The entities that hold a legal rights for patent applications filed by inventor Hakonarson Hakon:
Hakon Hakonarson from Malvern, US has applied for patents for these inventions. The list has both pending applications and granted patents:
METHODS OF DIAGNOSING AND TREATING ADHD IN BIOMARKER POSITIVE SUBJECTS
#2 | 2026-03-12GPCR LATROPHILIN-3 AS BIOMARKER FOR DETECTING INCREASED RISK FOR MILD BRAIN INJURY AND METHODS OF USE THEREOF FOR DIAGNOSIS AND TREATMENT OF THE SAME
#3 | 2026-01-22GENOMIC ALTERATIONS ASSOCIATED WITH SCHIZOPHRENIA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME
#4 | 2025-10-02COMPOSITIONS AND METHODS OF TREATING SEPSIS IN PATIENTS USING ANTI-LIGHT ANTIBODIES
#5 | 2025-04-24ASSOCIATION OF RARE RECURRENT GENETIC VARIATIONS TO ATTENTION-DEFICIT, HYPERACTIVITY DISORDER (ADHD) AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME
#6 | 2025-04-24METHODS OF DIAGNOSING AND TREATING TOURETTE SYNDROME
#7 | 2025-04-17NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ATTENTION DEFICIT DISORDER AND 22Q SYNDROME
#8 | 2024-06-13NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ANOREXIA NERVOSA AND BINGE EATING DISORDER
#9 | 2024-05-16METHODS OF DIAGNOSING AND TREATING ADHD IN BIOMARKER POSITIVE SUBJECTS
#10 | 2024-03-28METHODS OF DIAGNOSING AND TREATING ANXIETY DISORDER
#11 | 2024-03-07METHODS OF DIAGNOSING AND TREATING CONDUCT DISORDER
#12 | 2023-12-21ASSOCIATION OF RARE RECURRENT GENETIC VARIATIONS TO ATTENTION-DEFICIT, HYPERACTIVITY DISORDER (ADHD) AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME
#13 | 2023-11-09GENETIC ALTERATIONS ASSOCIATED WITH EOSINOPHILIC ESOPHAGITIS AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF DISEASE
#14 | 2023-10-05Association of genetic variations to diagnose and treat attention-deficit hyperactivity disorder (ADHD)
#15 | 2023-09-28GENOMIC ALTERATIONS ASSOCIATED WITH SCHIZOPHRENIA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME
#16 | 2023-09-28COMPOSITIONS AND METHODS FOR ENHANCING WEIGHT LOSS
#17 | 2023-02-16COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF LYMPHATIC SYSTEM DISORDERS
#18 | 2022-11-03NOVEL GENETIC MARKERS FOR POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) AND METHODS OF USE THEREOF FOR DIAGNOSIS AND TREATMENT OF THE SAME
#19 | 2022-11-03COMPOSITIONS AND METHODS FOR TREATMENT OF HEREDITARY CYSTATIN C AMYLOID ANGIOPATHY (HCCAA) AND OTHER NEURODEGENERATIVE DISORDERS ASSOCIATED WITH ABERRANT AMYLOID DEPOSITS
#20 | 2022-10-27COMPOSITIONS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH CLEC16A DYSFUNCTION OR LOSS
#21 | 2022-10-06COMPOSITIONS COMPRISING RARE GENETIC SEQUENCE VARIANTS ASSOCIATED WITH PULMONARY FUNCTION AND METHODS OF USE THEREOF FOR DIAGNOSIS AND TREATMENT OF ASTHMA IN AFRICAN AMERICAN PATIENTS
#22 | 2022-09-22METHODS OF DIAGNOSING AND TREATING TOURETTE SYNDROME
#23 | 2022-04-21Methods of diagnosing and treating anxiety disorder
#24 | 2022-04-21Methods of diagnosing and treating conduct disorder
#25 | 2022-04-14COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF LYMPHATIC SYSTEM DISORDERS
#26 | 2022-02-24IDENTIFICATION OF PEDIATRIC ONSET INFLAMMATORY BOWEL DISEASE LOCI AND METHODS FOR USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME
#27 | 2021-09-02Nonselective metabotropic glutamate receptor activators for treatment of anorexia nervosa and binge eating disorder
#28 | 2021-08-19ASSOCIATION OF RARE RECURRENT GENETIC VARIATIONS TO ATTENTION-DEFICIT, HYPERACTIVITY DISORDER (ADHD) AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME
#29 | 2021-08-19NOVEL TOPICAL FORMULATION FOR INTRADERMAL APPLICATION AND USES THEREOF
#30 | 2021-07-08Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome
#31 | 2021-05-13Methods of diagnosing and treating ADHD in biomarker positive subjects
#32 | 2020-12-10COMPOSITIONS AND METHODS FOR ENHANCING WEIGHT LOSS
#33 | 2020-10-15Compositions and methods for treatment of hereditary cystatin C amyloid angiopathy (HCCAA) and other neurodegenerative disorder associated with aberrant amyloid deposits
#34 | 2020-10-01Methods of diagnosing and treating Tourette syndrome
#35 | 2020-07-02Association of genetic variations to diagnose and treat attention-deficit hyperactivity disorder (ADHD)
#36 | 2020-03-12Methods for use in the diagnosis of autoimmune diseases
#37 | 2020-02-20Compositions and methods for the diagnosis and treatment of lymphatic system disorders
#38 | 2019-12-12Compositions and methods targeting the Th2 pathway for the treatment of asthma
#39 | 2019-10-10CXR4 as a susceptibility locus in juvenile idiopathic arthritis (JIA) and methods of use thereof for the treatment and diagnosis of the same
#40 | 2019-10-03Nonselective metabotropic glutamate receptor activators for treatment of anorexia nervosa and binge eating disorder
#41 | 2019-07-18Identification of pediatric onset inflammatory bowel disease loci and methods for use thereof for the diagnosis and treatment of the same
#42 | 2019-05-23IDENTIFICATION OF NOVEL LOCI IN ASTHMA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF ASTHMA
#43 | 2019-03-07Compositions and Methods for Treatment of Hereditary Cystatin C Amyloid Angiopathy (HCCAA) and Other Neurodegenerative Disorders Associated with Aberrant Amyloid Deposits
#44 | 2018-09-27Genetic Variants Underlying Human Cognition and Methods of Use Thereof as Diagnostic and Therapeutic Targets
#45 | 2018-08-09Mutations in and as causes of autosomal dominant infantile myofibromatosis
#46 | 2018-05-31GENETIC ALTERATIONS ASSOCIATED WITH AUTISM AND THE AUTISTIC PHENOTYPE AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF AUTISM
#47 | 2018-05-10Diagnosis and treatment of genetic alterations associated with eosinophilic esophagitis
#48 | 2018-04-26Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome
#49 | 2017-04-20Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome
#50 | 2017-03-30Methods of diagnosing and treating anxiety disorder
#51 | 2017-03-30Methods of diagnosing and treating conduct disorder
#52 | 2017-03-30METHODS OF DIAGNOSING AND TREATING TOURETTE SYNDROME
#53 | 2017-03-23Methods of diagnosing and treating autism
#54 | 2017-02-23Methods of treating autoimmune conditions in patients with genetic variations in DcR3 or in a DcR3 network gene
#55 | 2017-02-23Methods for use in combination for the treatment and diagnosis of autoimmune diseases
#56 | 2017-02-16Genetic alterations on chromosome 16 and methods of use thereof for the diagnosis and treatment of type 1 diabetes
#57 | 2017-01-12Methods to diagnose and treat attention-deficit, hyperactivity disorder (ADHD)
#58 | 2016-12-01CXCR4 as a susceptibility locus in juvenile idiopathic arthritis (JIA) and methods of use thereof for the treatment and diagnosis of the same
#59 | 2016-09-15GENOMIC ALTERATIONS ASSOCIATED WITH SCHIZOPHRENIA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME
#60 | 2016-08-25Genetic Alterations Associated with Autism and the Autistic Phenotype and Methods of Use Thereof for the Diagnosis and Treatment of Autism
#61 | 2016-03-24Mutations in PDGFRB and NOTCH3 as causes of autosomal dominant infantile myofibromatosis
#62 | 2016-02-18Common and rare genetic variations associated with common variable immunodeficiency (CVID) and methods of use thereof for the treatment and diagnosis of the same
#63 | 2016-02-04Schizophrenia-associated genetic loci identified in genome wide association studies and methods of use thereof
#64 | 2015-10-22Genetic alterations on chromosomes 21Q, 6Q and 15Q and methods of use thereof for the diagnosis and treatment of type 1 diabetes
#65 | 2015-02-19GENETIC VARIANTS UNDERLYING HUMAN COGNITION AND METHODS OF USE THEREOF AS DIAGNOSTIC AND THERAPEUTIC TARGETS
#66 | 2015-01-22Genetic alterations associated with type I diabetes and methods for use thereof for diagnosis and treatment
#67 | 2014-10-23Genetic Alterations Associated with Autism and the Autistic Phenotype and Methods of Use Thereof for the Diagnosis and Treatment of Autism
#68 | 2014-10-09Genetic Alterations Associated with Autism and the Autistic Phenotype and Methods of Use Thereof for the Diagnosis and Treatment of Autism
#69 | 2014-09-11Genetic alterations and methods of use thereof for the diagnosis and treatment of type I diabetes
#70 | 2013-11-28CXCR4 as a Susceptibility Locus in Juvenile Idiopathic Arthritis (JIA) and Methods of Use Thereof for the Treatment and Diagnosis of the Same
#71 | 2013-11-28Common and rare genetic variations associated with common variable immunodeficiency (CVID) and methods of use thereof for the treatment and diagnosis of the same
#72 | 2013-08-08Association of Rare Recurrent Genetic Variations to Attention-Deficit, Hyperactivity Disorder (ADHD) and Methods of Use Thereof for the Diagnosis and Treatment of the Same
#73 | 2013-02-07Markers for Obesity and Methods of Use Thereof
#74 | 2012-12-06Compositions and Methods for Diagnosing Genome Related Diseases and Disorders
#75 | 2012-04-19Genetic alterations on chromosome 12 and methods of use thereof for the diagnosis and treatment of type 1 diabetes
#76 | 2011-12-22Genetic Variants Underlying Human Cognition and Methods of Use Thereof as Diagnostic and Therapeutic Targets
#77 | 2011-11-03Genetic Alterations Associated with Schizophrenia and Methods of Use Thereof for the Diagnosis and Treatment of the Same
#78 | 2011-10-06Genetic Alterations Associated with Type I Diabetes and Methods of Use Thereof for Diagnosis and Treatment
#79 | 2011-09-29Genetic Alterations on Chromosomes 21q, 6q and 15q and Methods of Use Thereof for the Diagnosis and Treatment of Type I Diabetes
#80 | 2011-08-25Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatment of autism
#81 | 2011-08-18Asthma susceptibility loci located at chromosome 1q31 for use in diagnostic and therapeutic methods
#82 | 2011-07-21IDENTIFICATION OF PEDIATRIC ONSET INFLAMMATORY DISEASE LOCI AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME
#83 | 2010-08-26Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
#84 | 2009-01-29Sustained Release Formulation and Dosing Schedules of Leukotriene Synthesis Inhibitor for Human Therapy
#85 | 2008-11-27Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
79674 ⎘